Medtronic’s MDT acquisition of Covidien has produced a combined company that’s a force to be reckoned with in medical technology. Pairing Medtronic’s diversified product portfolio aimed at a wide ...

Medtronic ended its fiscal year with nominal sales growth and a steep profit drop, but analysts who cover the medical device company are confident a windfall is ahead, thanks to a strong lineup of ...

The experiences of one surgeon are raising questions about the costs and risks of a Medtronic Inc. (MDT) bone-growth product, threatening to pressure further the company's spinal business. According ...

Two patients who were injured by Medtronic's controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor ...

Two aspects of the recently reported fiscal third quarter were particularly noteworthy, from our perspective. First, management’s comments regarding the Guardian Connect continuous glucose monitor ...

An unresolved warning letter from the Food and Drug Administration continues to cause trouble for the heart device division at Fridley-based Medtronic. After releasing second-quarter results earlier ...

Fridley-based Medtronic, Inc., recently received a letter from two U.S. senators requesting information about the use of the company's Infuse bone-growth product and payments it made to clinical ...

Medtronic initially secured FDA clearance for the MiniMed 780G pump for people with Type 1 diabetes in early 2023. This past ...

Medtronic is buying Covidien in a tax-friendly move, but here are three other reasons the deal makes sense. The two companies have big and growing businesses that complement one another, too. Here are ...

MILWAUKEE — In January 2002, a group of Food and Drug Administration advisers met on whether to approve a powerful new biological agent that promised to revolutionize back surgery. The product was ...

Medtronic stock has seen its Fair Value Estimate climb modestly, rising from $98.63 to $99.90, with updates from sector analysts driving this slight adjustment. This shift reflects a balanced mix of ...